New BioNTX Member Center Portal Now Open!

BioNTX is grateful for our members! We have just unveiled our newest Member Benefit, an online Member Center where members can track events, search for grants and funding, browse other members, and post job openings which directly go on the main BioNTX website! There are many other amazing features for all our members to explore. Please check your inbox and spam for an email detailing how to login.

Industry Alliance Reports Growing Talent Pool, Increased K-12 Engagement, and Greater Capital Flow in North Texas 

The recent quarterly BHIANT meeting showcased a collaborative setting with industry leaders, local community colleges, and leaders in investment.

 

Overall, the meeting highlighted a dynamic and rapidly evolving landscape in North Texas, driven by technological breakthroughs, an increase in investments, a commitment to developing the workforce pipeline, and the promise of creating life saving treatments.

Oklahoma Biomanufacturing Leaders Advise State Governor and Business Executives on Future of Regional Industry 

(above left and right): Oklahoma Governor Kevin Stitt, and Jesse McCool, CSO at Wheeler Bio.

The Oklahoma Business Roundtable welcomed Oklahoma Governor Kevin Stitt and other state dignitaries to the historic Southern Hills Golf Club in Tulsa, OK, last week. The Roundtable, now in its third decade of service, has worked to advance the State's economy and resources. Leaders from biomanufacturing and life sciences convened to discuss strategic priorities for the state and the nation, while highlighting the vast opportunities coming to the region. The leaders shared a collective commitment to fostering innovation, collaboration, and workforce development to position Oklahoma and the southwest as a competitive hub for biomanufacturing in the region.

UNTHSC 'Latinos en Medicina' Summer Camp Empowers

Kids & Parents to Pursue STEM Higher Education

The UNT Health Science Center at Fort Worth has taken initiative in empowering the future by supporting your child's journey in health sciences. Offering invaluable resources and guidance to parents aiming to support their children's interest in health sciences; the week-long Latinos en Medicina Summer Camp focuses on equipping parents with the knowledge and tools necessary to nurture and sustain their children's enthusiasm and curiosity in health-related fields.

 

The program provided parents with essential knowledge and resources, enabling them to support their children's career aspirations in health sciences effectively. Moreover, the early exposure and guidance offered by the program empowers both parents and students to make informed decisions about future educational pursuits. By offering comprehensive guidance, and creating a supportive environment, the event encourages parents and their children to embark on the rewarding journey of exploring careers in the health sciences field.

BioNTX Business Director Aaron BenComo, MD speaks with parents and families 

 

En el Norte de Texas, el acceso a recursos y oportunidades para su desarrollo personal son nuestras prioridades. Unidos e informados, cambiaremos el mundo.

Good Days to Address Chronic Disease & Patient-centered Care

with Leadership Luncheon at Pegasus Park

The Chronic Disease Day Leadership Luncheon and Symposium in Dallas, Texas, aims to gather regional leaders from government, healthcare, biotech, and patient advocacy sectors. Chronic Disease Day serves as a crucial platform to raise awareness about the impact of chronic illnesses, which account for seven of the top 10 causes of death in the United States. This significant event will take place at Pegasus Park, home to the nation’s new ARPA-H Customer Experience hub. The symposium will underscore the area's dedication to addressing chronic diseases, spotlighting the region's comprehensive expertise and resources in tackling these health challenges.

Clinical Trial Infrastructure: A Blueprint for Future Breakthroughs

Join BioNTX in a pivotal conversation aimed at elevating North Texas' already robust clinical trial ecosystem to unprecedented heights. With world-class healthcare institutions, cutting-edge research, efficient transportation systems, and a diverse population, our region stands as a beacon of innovation in life-saving medical research. But how can we further enhance this ecosystem? In this discussion, we'll delve into the collaborative efforts between clinical scale manufacturing, clinical research organizations, and patient-engaging clinicians. By pooling our expertise and resources, we can unlock new opportunities for groundbreaking cures and treatments.

UTA Technology Innovation Center Garners National Recognition

With the acquisition of 20 utility patents in 2023, the University of Texas at Arlington has recently become the subject of national recognition. Acknowledged by the National Academy of Inventors, this milestone underscores the university's unwavering commitment to nurturing an atmosphere conducive to groundbreaking ideas. 

OTHER MEMBER NEWS

Scorpius Partners with Beyond Imagination to Advance AI Robotics Capabilities in Biomanufacturing 

Scorpius Holdings has announced a groundbreaking strategic partnership with Beyond Imagination, a US-based innovator in autonomous AI-powered humanoid robots. The collaboration looks to transform biomanufacturing productivity and strengthen US pandemic preparedness by leveraging cutting-edge AI robotics to address critical challenges such as rapid-scale demand for biomanufacturing and the shortage of skilled labor. Already in service throughout various industries, Beyond's advanced autonomous humanoids have been designed to learn from and work alongside human colleagues; and are expected to integrate seamlessly into biomanufacturing processes.

CBRE Earns Recognition on Forbes' Net Zero Leaders List

CBRE Group, Inc. has once again secured a spot on Forbes' prestigious Net Zero Leaders list, solidifying its position as the premier commercial real estate services company leading the charge toward a sustainable future. Forbes evaluated 100 U.S. companies, recognizing those best positioned to significantly reduce greenhouse gas emissions and achieve a net zero trajectory. The analysis considered each company's efforts to curb its own carbon footprint, as well as those of its power suppliers, vendors, and customers.

JPS Health Network's Transformative Expansion Will Reshape Healthcare Landscape in Tarrant County

JPS Health Network construction crews have been hard at work in Tarrant County, simultaneously improving existing facilities and constructing new ones. These projects are part of a larger master facility plan initiated after a 2018 bond election approved by Tarrant County voters, aimed at modernizing several JPS facilities and establishing a new hospital complex adjacent to the existing location to enhance mental health services. With Phase 1 scheduled for completion by late 2027 and the entire project expected to conclude in 2029, these efforts represent a significant step forward in improving healthcare infrastructure in the region.

North Texas Triumphs in Innovation Challenge at

Texas A&M-Chevron Engineering Academy

LaTasha Starr, a professor with the Texas A&M-Chevron Engineering Academy at Dallas College, expressed elation as her student team was named a finalist in the Community College Innovation Challenge (CCIC), organized by the American Association of Community Colleges and the National Science Foundation. Their project, AMBER (Autonomous Monitoring for Blaze Emergency Response), enhances fire monitoring and response using infrared technology and drones, inspired by a recent Texas Panhandle fire. 

Dallas College  students at the Texas A&M-Chevron Engineering Academy will present an engineering project in Washington, D.C.

Baylor Professor Awarded Fulbright Scholarship to

Study Adolescent Substance Use in Africa

Sungseek Moon, Ph.D.

Sungseek Moon, Ph.D., The Carl and Martha Lindner Endowed Chair for Global Studies and professor at Baylor University’s Diana R. Garland School of Social Work, has been honored as a 2024-2025 Fulbright U.S. Scholar to Kenya. This accolade places him among an esteemed cohort of scholars recognized by the U.S. government’s premier international educational exchange program. The prestigious fellowship offers Dr. Moon a unique opportunity to contribute to international diplomacy while conducting research and teaching at the University of Nairobi's College of Health Sciences. Leveraging his expertise in social work and public health.

UNTHSC Alumnus Receives AOCR Gold Medal

Distinguished Service

Dr. Frederick E. White, a 1977 graduate of the Texas College of Osteopathic Medicine, has been awarded the Gold Medal for Distinguished Service by the American Osteopathic College of Radiology (AOCR). This prestigious honor, given to only 16 individuals, acknowledges Dr. White's exceptional contributions to the field. His distinguished career includes 22 years in the U.S. Navy Medical Corps, leadership in Hemet Global Medical Group, and the development of ACGME-accredited residency programs. Dr. White continues to practice and mentor future medical professionals.

Frederick E. White, DO, FAOCR

 UTA Researchers Are Using Machine Learning

To Decode Dog Communication

Kenny Zhu, a computer science and engineering professor at The University of Texas at Arlington, is leading groundbreaking research funded by a National Science Foundation (NSF) Research Experiences for Undergraduates site grant.

 

This project aims to delve into the realm of understanding animal communication, particularly in dogs, by utilizing machine learning to translate their sounds into phonetic representations and, eventually, words.

Kenny Zhu, PhD, a professor of computer science and engineering at The University of Texas at Arlington

UTD and Seoul National University Develop Superman-Inspired Imager Chip for Mobile Devices

Researchers from The University of Texas at Dallas and Seoul National University have developed an imager chip inspired by Superman's X-ray vision, aiming to integrate it into mobile devices for detecting objects inside packages or behind walls. This technology, utilizing signals at 200 to 400 gigahertz instead of X-rays, was first demonstrated in 2022. Recently, advancements published in the March edition of IEEE Transactions on Terahertz Science and Technology have focused on miniaturizing the technology for handheld devices while improving image quality.

 

Supported by the Texas Instruments Foundational Technology Research Program and the Samsung Global Research Outreach Program, the research spanned 15 years, resulting in a remarkable improvement in pixel performance by 100 million times. 

Researchers, including electrical engineering student Walter Sosa Portillo BS’21 (left), have made advances to miniaturize an imager chip inspired by Superman’s X-ray vision for handheld  devices.

UTSW Receives Funding to Advance Trauma Care

Research and Innovation

UT Southwestern Medical Center is spearheading a new initiative funded by The University of Texas System and the state of Texas to enhance trauma patient care through cutting-edge research, product development, and training. Led by Dr. Benjamin Levi, Associate Professor of Surgery and Division Chief of Burn, Trauma, Acute, and Critical Care Surgery, the initiative has secured a grant from the Trauma Research and Combat Casualty Care Collaborative (TRC4). This funding will support research focused on pre-hospital care, innovative surgical technologies, drugs, therapies, trauma system registries, and wound management techniques. 

Lantern Pharma Granted Patent Certificate by Japanese Patent Office for LP-284 Drug Candidate's Composition of Matter

Lantern Pharma is paving the way to accelerating drug discovery. The AI-driven, oncology drug development company has announced the securement of a Japanese Patent for their drug candidate LP-284, a novel small molecule agent that damages DNA in cancer cells.

 

The patent covers the composition of matter for LP-284, a compound developed as a potential treatment for relapsed or refractory non-Hodgkin's lymphoma and specific types of sarcomas. LP-284 is the third molecule brought to clinical trials by Lantern Pharma using insights and support from the company's proprietary AI RADR® platform.

 

The value of the platform architecture is derived from over 60+ billion oncology-specific clinical and preclinical data points, more than 200+ advanced ML algorithms, and over 130,000+ patient records from 8,163+ datasets.

MEMBER SPOTLIGHT

Carocell Bio: Revolutionizing Eczema with Novel Peptides 

Carocell Bio is treating eczema with an innovative peptide-based approach. By harnessing the power of peptides to target and reduce inflammation in the skin barrier, they are able to treat a wide array of conditions; Atopic Dermatitis,  burns, scar formation, and skin ageing. 

 

Carocell was founded by Dr. Mike Davies, a published physician who sought to use peptides to reduce inflammation overall in the body. Their commitment to creating low cost treatments with peptides marks a transformative step towards overall anti-inflammatory technology.

Dr. Mike Davies, MD FRCS

FUNDING & MENTORSHIP OPPORTUNITIES

2024 iC³ Tech Transfer Showcase Application Portal is now OPEN

The Tech Transfer Showcase at the iC³ Life Science Summit provides a prime opportunity to present your most promising intellectual property to a select audience of industry leaders and investors, opening doors to potential collaborations and funding opportunities.

 

Submission Guidelines

    -  Application deadline August 12, 2024 at 11:59 pm

    -  Open to all university technology transfer offices in Texas

    -  Two submissions per university campus

    -  Applications will be reviewed by a panel of industry experts

    -  The top six applicants will advance to podium pitch at the annual iCSummit

    -  Winning applicants will be paired with an industry mentor to help craft and polish your presentation

“The Tech Transfer Showcase is an excellent example of how BioNTX is serving Texas universities and creating a strong life science ecosystem across the State of Texas,” said Jennifer Souter, Senior Licensing Associate, Texas Tech Office of Research Commercialization.

 Texas Tech Presidents' Innovative Startup Award 

Through these funding programs and opportunities, CPRIT grows the cancer-fighting ecosystem across Texas, providing life-extending results, and tangible economic benefits throughout the State.

National Science Foundation Expands Funding Opportunity

to Bolster Regional Innovation Engines

LOI due June 18, 2024

The U.S. National Science Foundation announced a funding opportunity to invest in a new set of NSF Regional Innovation Engines (NSF Engines) across the U.S. In January, NSF announced the 10 inaugural NSF Engines, and the latest opportunity looks to build upon that investment, pending congressional appropriations. 

Chiesi Rare Disease Golden Ticket Competition

Applications due June 30, 2024

The Chiesi Golden Ticket Competition awards startups and companies 2 (two) Golden Tickets to a US BioLabs site. Each Golden Ticket provides one year of fully paid individual bench space and membership at a fully equipped laboratory designed to accelerate early-stage startup working on research and development in the gene editing and/or relevant viral and non-viral delivery technologies, for treating rare hematology, immunology, ophthalmology, dermatology, inborn errors of metabolism or metabolic diseases. 

INDUSTRY EVENTS

Upcoming Events & Opportunities

DFW Nonprofit Resources Expo

 

Join the North Texas Nonprofit Institute for a day of networking and discovering mission-friendly business partners whose products and services are tailored to support your nonprofit organization.

 

June 18, 2024 | Hurst, TX

Key Points of Term Sheets

 

Join VelocityTX to delve into the essential elements of a term sheet, analyzing critical provisions like valuation, ownership structure, and liquidation preferences.

 

June 18, 2024 | Mission, TX

Coffee Connect with Plug and Play McKinney

 

Join Plug and Play for a morning of networking, collaboration, and caffeine-fueled creativity!

 

June 19, 2024 | McKinney, TX

Women in Bioscience


Join BioMedSA in welcoming Randi Brosterman Hutchens as she guides the discussion on the importance of building a personal advisory board.

 

June 20, 2024 | San Antonio, TX

AIM Health R&D Summit

 

Join Velocity TX to see the cutting-edge research, identify emerging trends and technologies, and network to foster economic development and growth.

 

June 24, 2024 | San Antonio, TX

Industry Spotlight Series

 

Join Morgan Stanley Private Wealth Management as they introduce a new virtual series, featuring seasoned Morgan Stanley Investment Bankers that provides unique insights into different industries.

 

June 26, 2024 | Virtual

Chronic Disease Day Leadership Summit

 

Join Good Days and Bio North Texas for a luncheon symposium with leaders in patient-centric care at the home of the new ARPA-H Customer Experience Hub.

 

July 8, 2024 | Dallas, TX

Building a Robust Life Science Ecosystem: The Bridge Between Research, Clinical Trials, & Manufacturing

 

 Join BioNTX for a discussion around how clinical scale manufacturing, clinical research organizations, and patient-engaging clinicians are working together to create more opportunities for life saving cures. 

 

July 17, 2024 | Plano, TX

Celebrating a Decade of Innovation and Excellence in North Texas

BioNTX is thrilled to announce our 10th Annual iC³ Life Science and Healthcare Innovation Summit, taking place on October 3rd and October 4th at the Arlington Convention Center at the Loews Hotel.

 

Join us for a two-day event where the most innovative minds from North Texas, the broader Southwest region and across the United States converge. Our Summit offers a vibrant platform for the bioscience and healthcare innovation to engage in thought-provoking discussions, share groundbreaking research, and delve into emerging technologies shaping the future of healthcare and biomedicine.

Thank You for Your Membership & Support!

June 17, 2024

This email was sent on behalf of {{TCDisplayName}} located at {{TCADDRAddress1}}{{TCADDRAddress2}}{{TCADDRCity}}{{TCADDRStateProvince}} {{TCADDRPostalCode}}To unsubscribe click here. If you have questions or comments concerning this email contact {{TCDisplayName}} at {{TCEmailAddress}}.